Cost matrix of support for transplantation
Patient . | Age (y) . | Type of transplant . | Cost, US$ . | Funding source and amount (US$) . | Patient outcome . |
---|---|---|---|---|---|
1 | 34 | Autologous | 2 800 | NGO, 1500; self, 1300 | Relapse after 3 years |
2 | 14 | Allogeneic | 7 600 | NGO, 5600; government, 2000 | Completed 4 years of independence from transfusion; partial chimerism |
3 | 17 | Autologous | 3 000 | NGO, 2000; self, 1000 | Continued to be in remission |
4 | 17 | Autologous | 4 000 | NGO, 2000; self, 2000 | In remission |
5 | 5 | Autologous | 1 100 | NGO | Died 8 months after transplant |
6 | 18 | Autologous | 3 000 | NGO, 1000; government, 1000; self, 1000 | In remission |
7 | 29 | Haploidentical | 15 000 | NGO, 8000; government, 2000; self, 5000 | In remission |
8 | 56 | Autologous | 10 000 | Government, 1000; self, 9000 | In remission |
9 | 18 | Autologous | 3 570 | NGO, 1000; self, 2570 | In remission |
Patient . | Age (y) . | Type of transplant . | Cost, US$ . | Funding source and amount (US$) . | Patient outcome . |
---|---|---|---|---|---|
1 | 34 | Autologous | 2 800 | NGO, 1500; self, 1300 | Relapse after 3 years |
2 | 14 | Allogeneic | 7 600 | NGO, 5600; government, 2000 | Completed 4 years of independence from transfusion; partial chimerism |
3 | 17 | Autologous | 3 000 | NGO, 2000; self, 1000 | Continued to be in remission |
4 | 17 | Autologous | 4 000 | NGO, 2000; self, 2000 | In remission |
5 | 5 | Autologous | 1 100 | NGO | Died 8 months after transplant |
6 | 18 | Autologous | 3 000 | NGO, 1000; government, 1000; self, 1000 | In remission |
7 | 29 | Haploidentical | 15 000 | NGO, 8000; government, 2000; self, 5000 | In remission |
8 | 56 | Autologous | 10 000 | Government, 1000; self, 9000 | In remission |
9 | 18 | Autologous | 3 570 | NGO, 1000; self, 2570 | In remission |
NGO, nongovernmental organization.